Patent · US Active

Formulations of (R)-2-amino-3-phenylpropyl carbamate

US10512609B2 · kind B2 · utility

34Cited by

24References

16Claims

0Family size

Assignee

Jazz Pharmaceuticals Ireland Limited · IE

Inventors

Clark Allphin · Seattle, US
Edwin Gerard Walsh · Dublin, IE

Key dates

Filing date	Dec 19, 2018
Grant date	Dec 24, 2019
Priority date	—
Expiry date	Dec 19, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/34
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to immediate release formulations of (R)-2-amino-3-phenylpropyl carbamate and methods of using the same to treat disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.